3rd Quarter - Report
HOLLAND & KNIGHT LLP for TEVA PHARMACEUTICALS USA, INC.
Firm
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Global supply chain issues; National Defense Authorization Act.
Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER ARMSTRONG New | — |
| PAUL S. BOCK | — |
| MICHAEL WERNER | — |
Pharmacy PHA
Global supply chain issues; National Defense Authorization Act.
Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER ARMSTRONG New | Attorney, Office of Special Counsel; Investigative Counsel, Senate Finance Committee; Oversight Counsel, House Ways and Means Committee; Chief Oversight Counsel, Senate Finance Committee |
| PAUL S. BOCK | — |
| MICHAEL WERNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.